Israele - ebraico - Ministry of Health

abic veterinary products ltd - norfloxacin nicotinate 100 % - powder for solution - for the treatment of infections in chickens and turkeys caused by bacteria sensitive to norfloxacin, only after the sensitivity of the bacteria has been proven and it has been found that there is no alternative treatment (proven resistance to other agents).

Israele - ebraico - Ministry of Health

abic veterinary products ltd - enrofloxacin 100 g/l - solution - for the treatment of infections diseases caused by bacteria sensitive to enrofloxacin in broilers and turkeys sensitive to , only after the sensitivity of the bacteria has been proven and it has been found that there is no alternative treatment (proven resistance to other agents).

Israele - ebraico - Ministry of Health

m.p.vet ltd - enrofloxacin 10 % - solution - for the treatment of infections caused by bacteria sensitive to enrofloxacin in broilers, only after the sensitivity of the bacteria has been confimed and it has been found that there is no alternative treatment ( proven resistance to other agents).

Israele - ebraico - Ministry of Health

biovac ltd, israel - enrofloxacin 10 % - solution - for the treatment of infections caused by bacteria sensitive to enrofloxacin in turkeys and broilers, only after the sensitivity of the bacteria has been proven and it has been found that there is no alternative treatment (proven resistance to other agents).

Israele - ebraico - Ministry of Health

eliezer linevitz ltd. - marbofloxacin - תמיסה להזרקה - marbofloxacin 100 mg/ml - in cattle: treatment of respiratory infections caused by sensitive strains of pasteurella multocida, pasteurella haemolytica bovis. in sows: treatment of metritis mastitis agalactia syndrome caused by bacterial strains sensitive to marbofloxacin treatment in both species should be given only after the sensitivity of the bacteria has been proven and it has been found that there is no alternative treatment (proven resistance to other agents).

Israele - ebraico - Ministry of Health

glaxo smith kline (israel) ltd - mepolizumab - אבקה להכנת תמיסה לזריקה - mepolizumab 100 mg - mepolizumab

Israele - ebraico - Ministry of Health

astra zeneca (israel) ltd - budesonide micronized - ספריי לאף - budesonide micronized 0.64 mg/ml - budesonide - budesonide - seasonal and perennial allergic rhinitis, and vasomotor rhinitis. preventively against nasal polyps after polypectomy. symptomatic treatment in nasal polyposis.

Israele - ebraico - Ministry of Health

astra zeneca (israel) ltd - budesonide micronized - ספריי לאף - budesonide micronized 1.28 mg/ml - budesonide - budesonide - seasonal and perennial allergic rhinitis, and vasomotor rhinitis. preventively against nasal polyps after polypectomy. symptomatic treatment in nasal polyposis.

Israele - ebraico - Ministry of Health

merck serono ltd - follitropin alfa - תמיסה להזרקה - follitropin alfa 600 iu/ml - follitropin alfa - follitropin alfa - gonal-f followed by chorionic gonadotrophin (hcg), is recommended for the stimulation of follicular development and ovulation in women with hypothalamic-pituitary dysfunction who present with either oligomenorrhoea or amenorrhoea. these women are classified as w.h.o group ii patients and usually receive clomiphene citrate as primary therapy. they have evidence of endogenous oestrogen production and thus will either spontaneously menstruate or experience withdrawal bleeding after progestagen administration. polycystic ovarian disease (pcod) is part of the who ii classification and is present in the majority of these patients. 2) gonal-f is indicated for stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertillization (ivf), gamete intra-fallopian transfer (gift) and zogote intra-fallopian transfer (zift). 3) gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermat

Israele - ebraico - Ministry of Health

merck serono ltd - choriogonadotropin alfa - תמיסה להזרקה - choriogonadotropin alfa 250 mcg / 0.5 ml - choriogonadotropin alfa - choriogonadotropin alfa - for women undergoing superovulation prior to assisted reproductive techniques such as in vitro fertilization (ivf) : ovitrelle is administered to trigger final follicular maturation and luteinisation after stimulation of follicular growth. - anovulatory or oligo-ovulatory women: ovitrelle is administered to trigger ovulation and luteinisation in anovulatory or oligo-ovulatory patients after stimulation of follicular growth.